Dottikon ES Holding AG (SWX:DESN)

Market Cap	3.65B -9.6%
Revenue (ttm)	439.92M +12.0%
Net Income	103.60M -1.9%
EPS	7.49 -1.9%
Shares Out	13.82M
PE Ratio	35.23
Forward PE	27.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	850
Open	264.00
Previous Close	264.00
Day's Range	260.50 - 268.00
52-Week Range	259.00 - 396.00
Beta	0.99
Analysts	Hold
Price Target	386.50 (+47.8%)
Earnings Date	Nov 27, 2026

About Dottikon ES Holding AG

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine buildin...

• Industry: Chemicals
• Sector: Materials
• Founded: 1913
• Employees: 900
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: DESN

Financial Performance

In fiscal year 2026, Dottikon ES Holding AG's revenue was 439.92 million, an increase of 12.03% compared to the previous year's 392.68 million. Earnings were 103.60 million, a decrease of -1.87%.

Analyst Summary

According to 2 analysts, the average rating for DESN stock is "Hold." The 12-month stock price target is CHF 386.50, which is an increase of 47.80% from the latest price.

Price Target

CHF 386.50

(47.80% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error